BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Pharm Country

  Enzon Pharmaceuticals, Inc. Presents Final Analysis of Phase II PEG-SN38 (EZN-2208) Study in Patients With Metastatic Breast Cancer at 2012 American Society of Clinical Oncology Meeting

  June 5, 2012

   · 

  4 min read
• Drug Development

  Addex Therapeutics Partner to Initiate Phase 2 Clinical Trial of ADX71149 for the Treatment of Major Depressive Disorder With Anxiety Symptoms

  June 5, 2012

   · 

  6 min read
• Galapagos NV to Present GLPG0634 Phase II POC Results at EULAR

  June 5, 2012

   · 

  4 min read
• Pharm Country

  Immunovative, Inc. Announces That American Society of Clinical Oncology Abstract “Response of HER2+ Breast Cancer Patients to Allogeneic Cell Immunotherapy” Available On-Line

  June 5, 2012

   · 

  4 min read
• BioMidwest

  EnteroMedics Announces First Commercial Implants of the Maestro(R) Rechargeable System

  June 5, 2012

   · 

  5 min read
• Pharm Country

  The Medicines Company Announces Intention to Offer $200 Million of Convertible Notes

  June 5, 2012

   · 

  7 min read
• BioForest

  IsoRay, Inc. Announces World’s First Cesium-131 Mesh Treatment for Meningioma Brain Tumors

  June 5, 2012

   · 

  5 min read
• Biotech Beach

  Micro Imaging Technology, Inc. Announces Funding Commitments

  June 5, 2012

   · 

  3 min read
• FDA

  SoloHealth Inc. Announces FDA Approval of its SoloHealth Station

  June 5, 2012

   · 

  3 min read
• Pharm Country

  Kadmon Pharmaceuticals Launches 600 mg/day Ribasphere(R) RibaPak(R) to Provide Added Dosing Control for Triple Therapy Treatment of Chronic Hepatitis C

  June 5, 2012

   · 

  9 min read